• iMSC-Exosomes Reprogram Macrophages to Alleviate Disc Degene

  2026-05-27

  This study uncovers how exosomes secreted by human iPSC-derived mesenchymal stem cells (iMSCs) disrupt the harmful feedback loop between senescent nucleus pulposus (NP) cells and pro-inflammatory macrophages in intervertebral disc degeneration (IDD). By delivering miR-100-5p and reprogramming macrophage metabolism, iMSC-exosomes offer new mechanistic insight and a potential therapeutic avenue for IDD intervention.

• Translational Apoptosis Research: Src/JNK Insights & Assay S

  2026-05-26

  This thought-leadership article explores the mechanistic underpinnings of apoptosis in osteosarcoma, focusing on the Src/JNK pathway and its translational significance. It critically discusses the role of advanced cell death analysis tools, especially the Annexin V-FITC/7-AAD Apoptosis Kit, for bridging discovery science with therapeutic innovation. The article contrasts standard cell viability assays with mechanistically-driven approaches, integrates recent evidence from Corynoline research, and provides actionable assay guidance for translational researchers.

• WEHI-539: Applied BCL-XL Inhibitor Workflows for Apoptosis R

  2026-05-26

  WEHI-539 empowers researchers to dissect BCL-XL-mediated apoptosis with unprecedented selectivity, unlocking new strategies for overcoming chemoresistance and cancer stem cell survival. This guide delivers actionable protocols, troubleshooting tactics, and translational insights that build on recent breakthroughs in synthetic lethal targeting.

• IWR-1-endo (SKU B2306): Reliable Wnt Signaling Inhibition in

  2026-05-25

  This article addresses persistent laboratory challenges in cell viability, proliferation, and cytotoxicity assays by exploring how IWR-1-endo (SKU B2306), a nanomolar-potency Wnt signaling inhibitor, delivers consistent and data-backed performance. Through scenario-driven Q&A, we demonstrate its advantages in assay reproducibility, mechanistic clarity, and workflow integration for advanced biomedical research.

• IGF2BP2 Inhibition Disrupts Glycolysis and Cell Cycle in Ova

  2026-05-25

  This study identifies IGF2BP2 as a crucial m6A reader sustaining cell cycle progression and glycolytic metabolism in ovarian cancer. Through integrative analysis and functional assays, the authors demonstrate that targeting IGF2BP2 impairs cancer cell proliferation and glucose metabolism, highlighting its value as a candidate for precision oncology interventions.

• Quaternization Enables Lung-Selective mRNA Delivery via Nano

  2026-05-24

  The reference study demonstrates that quaternizing lipid-like nanoassemblies redirects their organ tropism from the spleen to the lung, enabling highly efficient and selective mRNA delivery to pulmonary immune cells after intravenous administration. This finding simplifies the design of lung-targeted mRNA therapeutics by removing the need for targeting ligands and may broaden the clinical applicability of mRNA-based interventions.

• L-Ornithine in Urea Cycle & CNS Toxicity Research: Protocols

  2026-05-23

  L-Ornithine ((S)-2,5-diaminopentanoic acid) is transforming metabolic and neurotoxicity studies, powering precision models of urea cycle dysfunction and astrocyte glycolysis. APExBIO’s high-purity L-Ornithine (SKU: B8919) brings reproducibility and robust assay design to the forefront of experimental workflows.

• CP-673451: Selective PDGFRα/β Inhibitor for Targeted Cancer

  2026-05-22

  CP-673451 is a highly selective PDGFRα/β inhibitor used in cancer research to block PDGFR-mediated signaling and suppress tumor angiogenesis. Its nanomolar potency and kinase selectivity enable precise modulation of tyrosine kinase pathways, with validated efficacy in xenograft and glioblastoma models.

• CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce

  2026-05-22

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit enables stable, covalent fluorescent labeling of cells for long-term tracking in both in vitro and in vivo studies. It is optimized for workflows requiring persistent cell lineage tracing and proliferation analysis, but is not suitable for short-term or reversible labeling. Researchers should select this kit for applications where durability and minimum impact on cell function are required.

• Puerarin Modulates Gut Microbiota and Thermogenesis in T2D M

  2026-05-21

  This study demonstrates that puerarin, a bioactive isoflavone, improves glucose and lipid metabolism in type 2 diabetic mice by restoring gut microbiota balance and promoting adipose tissue thermogenesis. These findings reveal new mechanistic insights into phytotherapeutic interventions for metabolic disorders and suggest future directions for metabolic disease research.

• EDI3 Inhibition Reduces Growth in HER2-Resistant Breast Canc

  2026-05-21

  Keller et al. demonstrated that targeting the glycerophosphodiesterase EDI3 significantly reduces cell viability and tumor growth in ER-HER2+ breast cancer cells with resistance to HER2-targeted therapies. This study identifies EDI3 as a novel metabolic vulnerability, with implications for overcoming therapeutic resistance in aggressive breast cancer subtypes.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Mechanism and Benchm

  2026-05-20

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is an affinity-purified, Cy3-conjugated secondary antibody enabling highly sensitive mouse IgG detection in immunoassays. It achieves robust signal amplification and clear visualization across immunofluorescence, western blotting, and flow cytometry platforms. This reagent, supplied by APExBIO, is validated for research use and offers enhanced reliability in quantitative proteomics workflows.

• 2-NBDG for Quantitative Glucose Uptake: Applied Workflows &

  2026-05-20

  2-NBDG enables precise, real-time measurement of cellular glucose uptake using fluorescence. This article details experimental workflows, optimization strategies, and troubleshooting tips to maximize reproducibility and sensitivity across diverse disease models.

• Neurogenetic Gradients of Nurr1+ Neurons in Rat Claustrum De

  2026-05-19

  Fang et al. (2021) provide a comprehensive developmental atlas of Nurr1-positive neurons in the rat claustrum and adjacent lateral cortex, resolving longstanding ambiguities regarding their birthdating and spatial patterning. By integrating EdU labeling with in situ hybridization, the study reveals distinct neurogenetic gradients and sequential neuronal generation, offering critical insights for researchers mapping neural development.

• Nile Red for Lipid Distribution Imaging: Protocols & Insight

  2026-05-19

  Nile Red (Nile blue oxazone) empowers researchers to achieve selective, sensitive intracellular lipid droplet staining, enabling nuanced studies of lipid metabolism and storage. This article delivers stepwise protocols, advanced troubleshooting, and translational insights from recent cancer biomarker research—demonstrating how APExBIO’s Nile Red bridges discovery and reproducibility in lipidomics.

499 records 6/34 page Previous Next First page 上5页 678910 下5页 Last page